FlashDx
闪量科技
FlashDx
Biotech/Healthcare
Shanliang Technology provides point-of-care molecular diagnostic solutions based on microfluidics. Its proprietary FDx-1000 rapid molecular diagnostic platform enables fully enclosed, one-click, sample-to-result rapid multiplex nucleic acid testing.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.